Skip to main content

Table 3 Univariate and multivariate analyses for the performance of axillary lymph node dissection in 7478 Korean patients who met the Z0011 criteria

From: Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis

Variables

Univariate analysis

Multivariate analysisa

Unadjusted OR

95% CI

p value

Adjusted OR

95% CI

p value

Age at surgery

ā€ƒā€‰<ā€‰40

Ref

Ā Ā Ā Ā Ā 

ā€ƒ40ā€“49

1.072

0.908ā€“1.267

0.410

Ā Ā Ā 

ā€ƒ50ā€“59

1.071

0.905ā€“1.268

0.423

Ā Ā Ā 

ā€ƒ60ā€“69

1.078

0.888ā€“1.309

0.446

Ā Ā Ā 

ā€ƒ70ā€“79

0.987

0.761ā€“1.279

0.920

Ā Ā Ā 

ā€ƒā€‰>ā€‰80

0.743

0.413ā€“1.340

0.324

Ā Ā Ā 

pT

ā€ƒpT1

Ref

Ā Ā 

Ref

Ā Ā 

ā€ƒpT2

1.604

1.455ā€“1.767

ā€‰<ā€‰0.0001

1.458

1.294ā€“1.642

ā€‰<ā€‰0.0001*

Multifocality

ā€ƒSingle lesion

Ref

Ā Ā Ā Ā Ā 

ā€ƒMultifocal lesion

1.184

0.972ā€“1.442

0.094

Ā Ā Ā 

Histologic subtype

ā€ƒIDC

1.173

1.035ā€“1.330

0.013

1.279

0.992ā€“1.649

0.058

ā€ƒOthers

Ref

Ā Ā 

Ref

Ā Ā 

Histologic grade

ā€ƒI

Ref

Ā Ā 

Ref

Ā Ā 

ā€ƒII

0.856

0.736ā€“0.997

0.046

0.715

0.599ā€“0.852

ā€‰<ā€‰0.001*

ā€ƒIII

1.177

0.998ā€“1.389

0.053

0.872

0.707ā€“1.076

0.202

Lymphatic invasion

ā€ƒNo

Ref

Ā Ā 

Ref

Ā Ā 

ā€ƒYes

1.549

1.388ā€“1.728

ā€‰<ā€‰0.0001

1.519

1.351ā€“1.709

ā€‰<ā€‰0.0001*

ER/HER2 status

ā€ƒERā€‰+ā€‰/HER2-

Ref

Ā Ā 

Ref

Ā Ā 

ā€ƒHER2ā€‰+ā€‰

1.353

1.170ā€“1.564

ā€‰<ā€‰0.0001

1.263

1.066ā€“1.497

0.007*

ā€ƒER-/HER2-

1.336

1.129ā€“1.582

0.001

1.246

1.015ā€“1.529

0.036*

  1. pT Pathologic tumor stage, IDC Invasive ductal carcinoma, ER Estrogen receptor, HER2, human epidermal growth factor receptor 2, OR Odds ratio, CI Confidence interval
  2. aAdjusted for pathologic tumor stage, histologic subtype, histologic grade, lymphatic invasion, and ER/HER2 status
  3. *P valueā€‰<ā€‰0.05